Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on German News Wire.
Press releases published on April 15, 2025
HydroGraph to Present at the Emerging Growth Conference on April 16, 2025
GlobeNewswire
·
April 15, 2025
VANCOUVER, British Columbia, April 15, 2025 (GLOBE NEWSWIRE) -- HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGCPF) (the “Company” or “HydroGraph”) a sustainable commercial manufacturer of pristine graphene, (the “Company”) is pleased to announce that …
Swarm joins Hivello for new reward opportunities
GlobeNewswire
·
April 15, 2025
TORONTO, April 15, 2025 (GLOBE NEWSWIRE) -- Blockmate Ventures Inc (TSX.V: MATE) (OTCQB: MATEF) (FSE: 8MH1) (“Blockmate” or the “Company”) is pleased to announce that its investee, Hivello Holdings, has integrated the Swarm network into its platform to …
First Atlantic Nickel Reports DTR Metallurgical Results from RPM Hole 2: Magnetic Concentrate of 1.32% Nickel & 1.95% Chromium Over Entire 216 Meter Drill Hole
GlobeNewswire
·
April 15, 2025
VANCOUVER, British Columbia, April 15, 2025 (GLOBE NEWSWIRE) -- First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) ("First Atlantic" or the "Company") is pleased to announce Davis Tube Recovery (DTR) metallurgical test results from drill …
HepaRegeniX completes €21.5 million financing to support clinical advancement of HRX-215 for liver regeneration
GlobeNewswire
·
April 15, 2025
Tuebingen, Germany, April 15, 2025 – HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver diseases, today announced the second closing and completion of a €21.5 million financing round with …
1ST Biotherapeutics Joins The Michael J. Fox Foundation’s LITE Program to Advance LRRK2-Based Parkinson’s Disease Research
GlobeNewswire
·
April 15, 2025
Focus on the discovery of next-generation LRRK2 inhibitors to unlock novel biological mechanisms of action and advance new treatment options YONGIN, South Korea, April 15, 2025 – 1ST Biotherapeutics, Inc. (1STBIO), a clinical-stage biopharmaceutical …
Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases
GlobeNewswire
·
April 15, 2025
Partnership bolsters Boehringer’s autoimmune and inflammatory disease pipeline portfolio aiming to tackle areas of high unmet patient need. The agreement focuses on further research and development of a novel, first-in-class bispecific …
Cabka N.V. Publishes 2024 Integrated Annual Report with ESRS-Aligned Sustainability Statement
GlobeNewswire
·
April 15, 2025
PRESS RELEASE Amsterdam 15 April 2025. Cabka N.V. (together with its subsidiaries “Cabka”, or the “Company”), a company specialized in transforming hard-to-recycle plastic waste into innovative Reusable Transport Packaging (RTP), today announces the …